

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.70157238 |
| 2 | lens fiber cell development (GO:0070307) | 6.28986603 |
| 3 | positive regulation of isotype switching (GO:0045830) | 5.73703287 |
| 4 | activated T cell proliferation (GO:0050798) | 5.70336802 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.91604249 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91604249 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90767341 |
| 8 | positive regulation of DNA recombination (GO:0045911) | 4.83348659 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.82210713 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 4.82210713 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.65764069 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.65764069 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58439026 |
| 14 | positive regulation of B cell mediated immunity (GO:0002714) | 4.13855156 |
| 15 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.13855156 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.11703593 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.10228044 |
| 18 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.07320659 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.99275811 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 3.95413506 |
| 21 | response to laminar fluid shear stress (GO:0034616) | 3.92307275 |
| 22 | toxin transport (GO:1901998) | 3.90423223 |
| 23 | regulation of isotype switching (GO:0045191) | 3.88436261 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 3.82714334 |
| 25 | detection of bacterium (GO:0016045) | 3.80562196 |
| 26 | lymphocyte migration (GO:0072676) | 3.80021030 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79437273 |
| 28 | detection of other organism (GO:0098543) | 3.77586284 |
| 29 | interferon-gamma production (GO:0032609) | 3.73578486 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.73100188 |
| 31 | positive regulation of immunoglobulin production (GO:0002639) | 3.69364161 |
| 32 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.65326224 |
| 33 | leukocyte aggregation (GO:0070486) | 3.65174557 |
| 34 | histamine transport (GO:0051608) | 3.63868376 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.60800756 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.60800756 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.60800756 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.60800756 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.60800756 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.60800756 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.58350235 |
| 42 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.54896882 |
| 43 | UMP metabolic process (GO:0046049) | 3.54896882 |
| 44 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.54896882 |
| 45 | UMP biosynthetic process (GO:0006222) | 3.54896882 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.53265666 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.52636403 |
| 48 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.52631095 |
| 49 | valine metabolic process (GO:0006573) | 3.51303523 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.50150780 |
| 51 | cysteine metabolic process (GO:0006534) | 3.48880362 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.48062479 |
| 53 | protein carboxylation (GO:0018214) | 3.48062479 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.47388531 |
| 55 | glyoxylate metabolic process (GO:0046487) | 3.45553551 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43919844 |
| 57 | phospholipid efflux (GO:0033700) | 3.43250845 |
| 58 | kynurenine metabolic process (GO:0070189) | 3.41567893 |
| 59 | lysine metabolic process (GO:0006553) | 3.39916910 |
| 60 | lysine catabolic process (GO:0006554) | 3.39916910 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39912836 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.36228622 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.32892102 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.32892102 |
| 65 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.32878161 |
| 66 | fatty acid beta-oxidation (GO:0006635) | 3.31545860 |
| 67 | tryptophan catabolic process (GO:0006569) | 3.30996721 |
| 68 | indole-containing compound catabolic process (GO:0042436) | 3.30996721 |
| 69 | indolalkylamine catabolic process (GO:0046218) | 3.30996721 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.29608670 |
| 71 | regulation of necroptotic process (GO:0060544) | 3.29175998 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.28732811 |
| 73 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27228660 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.26818288 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26167482 |
| 76 | cellular response to exogenous dsRNA (GO:0071360) | 3.23296674 |
| 77 | response to peptidoglycan (GO:0032494) | 3.22538943 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 3.19793650 |
| 79 | cell-cell junction maintenance (GO:0045217) | 3.19739059 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.15449222 |
| 81 | amyloid precursor protein catabolic process (GO:0042987) | 3.15349621 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.15027367 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.15027367 |
| 84 | complement activation, alternative pathway (GO:0006957) | 3.14963007 |
| 85 | fatty acid catabolic process (GO:0009062) | 3.10126824 |
| 86 | growth hormone receptor signaling pathway (GO:0060396) | 3.09033333 |
| 87 | amino-acid betaine metabolic process (GO:0006577) | 3.09031618 |
| 88 | fatty acid oxidation (GO:0019395) | 3.07790711 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.06954563 |
| 90 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.06758916 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.06491599 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.06254529 |
| 93 | regulation of B cell mediated immunity (GO:0002712) | 3.06088645 |
| 94 | negative regulation of necroptotic process (GO:0060546) | 3.04185032 |
| 95 | detection of external biotic stimulus (GO:0098581) | 3.04053918 |
| 96 | lipid oxidation (GO:0034440) | 3.03662801 |
| 97 | bile acid biosynthetic process (GO:0006699) | 3.01707078 |
| 98 | creatine metabolic process (GO:0006600) | 3.00127667 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.98823762 |
| 100 | cellular response to fluid shear stress (GO:0071498) | 2.97663963 |
| 101 | leukocyte degranulation (GO:0043299) | 2.95272304 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94620578 |
| 103 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94620578 |
| 104 | mast cell activation involved in immune response (GO:0002279) | 2.94459575 |
| 105 | mast cell degranulation (GO:0043303) | 2.94459575 |
| 106 | protein-lipid complex remodeling (GO:0034368) | 2.94442820 |
| 107 | macromolecular complex remodeling (GO:0034367) | 2.94442820 |
| 108 | plasma lipoprotein particle remodeling (GO:0034369) | 2.94442820 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 2.93416894 |
| 110 | glucose 6-phosphate metabolic process (GO:0051156) | 2.91575244 |
| 111 | regulation of defense response to virus by virus (GO:0050690) | 2.90605278 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 2.89973181 |
| 113 | mast cell activation (GO:0045576) | 2.89538792 |
| 114 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88761282 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.86741093 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86311925 |
| 117 | mannose metabolic process (GO:0006013) | 2.86090564 |
| 118 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86019133 |
| 119 | phospholipid homeostasis (GO:0055091) | 2.85553985 |
| 120 | monocarboxylic acid catabolic process (GO:0072329) | 2.85222548 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.84815171 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.84815171 |
| 123 | reverse cholesterol transport (GO:0043691) | 2.83995955 |
| 124 | acetyl-CoA metabolic process (GO:0006084) | 2.83332580 |
| 125 | drug transmembrane transport (GO:0006855) | 2.81007323 |
| 126 | urea cycle (GO:0000050) | 2.80733341 |
| 127 | urea metabolic process (GO:0019627) | 2.80733341 |
| 128 | bile acid metabolic process (GO:0008206) | 2.79873202 |
| 129 | cellular modified amino acid catabolic process (GO:0042219) | 2.79002520 |
| 130 | plasma lipoprotein particle assembly (GO:0034377) | 2.77942571 |
| 131 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.77824307 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.76921977 |
| 133 | response to fluid shear stress (GO:0034405) | 2.76210857 |
| 134 | fatty acid transmembrane transport (GO:1902001) | 2.75473933 |
| 135 | microglial cell activation (GO:0001774) | 2.75188481 |
| 136 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.73803190 |
| 137 | cholesterol homeostasis (GO:0042632) | 2.73196242 |
| 138 | carnitine metabolic process (GO:0009437) | 2.72358074 |
| 139 | regulation of protein activation cascade (GO:2000257) | 2.71656990 |
| 140 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.70721299 |
| 141 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70558725 |
| 142 | triglyceride homeostasis (GO:0070328) | 2.70242055 |
| 143 | acylglycerol homeostasis (GO:0055090) | 2.70242055 |
| 144 | regulation of tolerance induction (GO:0002643) | 2.70219837 |
| 145 | bile acid and bile salt transport (GO:0015721) | 2.70176257 |
| 146 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69957054 |
| 147 | aspartate family amino acid catabolic process (GO:0009068) | 2.69805395 |
| 148 | sterol homeostasis (GO:0055092) | 2.69306563 |
| 149 | negative regulation of interleukin-12 production (GO:0032695) | 2.69160736 |
| 150 | regulation of immunoglobulin production (GO:0002637) | 2.68806529 |
| 151 | ethanol oxidation (GO:0006069) | 2.68781321 |
| 152 | positive regulation of lipid catabolic process (GO:0050996) | 2.68694156 |
| 153 | regulation of sequestering of triglyceride (GO:0010889) | 2.68170328 |
| 154 | regulation of mast cell degranulation (GO:0043304) | 2.68046712 |
| 155 | response to type I interferon (GO:0034340) | 2.68028246 |
| 156 | regulation of triglyceride metabolic process (GO:0090207) | 2.67377072 |
| 157 | cellular extravasation (GO:0045123) | 2.67116349 |
| 158 | lymphocyte homeostasis (GO:0002260) | 2.66745206 |
| 159 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.66460724 |
| 160 | aromatic amino acid family metabolic process (GO:0009072) | 2.66190938 |
| 161 | protein-lipid complex assembly (GO:0065005) | 2.65841997 |
| 162 | regulation of necrotic cell death (GO:0010939) | 2.64538168 |
| 163 | cellular response to growth hormone stimulus (GO:0071378) | 2.64486545 |
| 164 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.63861166 |
| 165 | cellular response to type I interferon (GO:0071357) | 2.62578800 |
| 166 | type I interferon signaling pathway (GO:0060337) | 2.62578800 |
| 167 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.62481598 |
| 168 | detection of biotic stimulus (GO:0009595) | 2.62352793 |
| 169 | response to interleukin-15 (GO:0070672) | 2.61978661 |
| 170 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.61112010 |
| 171 | positive regulation of steroid metabolic process (GO:0045940) | 2.60927966 |
| 172 | dopamine transport (GO:0015872) | 2.60775066 |
| 173 | regulation of complement activation (GO:0030449) | 2.60261342 |
| 174 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59265938 |
| 175 | negative regulation of fibrinolysis (GO:0051918) | 2.59186085 |
| 176 | cholesterol efflux (GO:0033344) | 2.58538687 |
| 177 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.58096795 |
| 178 | nitrogen cycle metabolic process (GO:0071941) | 2.57490855 |
| 179 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.57427469 |
| 180 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57274344 |
| 181 | transcytosis (GO:0045056) | 2.57248885 |
| 182 | negative regulation of lipase activity (GO:0060192) | 2.57018748 |
| 183 | carnitine shuttle (GO:0006853) | 2.56814220 |
| 184 | positive regulation of B cell activation (GO:0050871) | 2.56273813 |
| 185 | alpha-amino acid catabolic process (GO:1901606) | 2.55976596 |
| 186 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.55739629 |
| 187 | response to mercury ion (GO:0046689) | 2.55445740 |
| 188 | macrophage activation (GO:0042116) | 2.54418327 |
| 189 | positive regulation of adaptive immune response (GO:0002821) | 2.54183439 |
| 190 | low-density lipoprotein particle clearance (GO:0034383) | 2.54160525 |
| 191 | cholesterol catabolic process (GO:0006707) | 2.53777041 |
| 192 | sterol catabolic process (GO:0016127) | 2.53777041 |
| 193 | ethanol metabolic process (GO:0006067) | 2.53599973 |
| 194 | tricarboxylic acid metabolic process (GO:0072350) | 2.53283803 |
| 195 | cellular response to interferon-beta (GO:0035458) | 2.53089357 |
| 196 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.52954979 |
| 197 | positive regulation of T cell cytokine production (GO:0002726) | 2.52547971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.15304671 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.58803994 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.48521600 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.22903818 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.81053030 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.66584384 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.02236338 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71125519 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56337419 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43739935 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38855050 |
| 12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.28453133 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09597571 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00117307 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98385192 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97528552 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88730724 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87991750 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85142028 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79308055 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79223350 |
| 22 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.76951313 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71886924 |
| 24 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71291620 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69788010 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69389615 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.66566557 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66177600 |
| 29 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65109237 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64962408 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64459858 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64176636 |
| 33 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62001051 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60107157 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58883531 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51098867 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51006991 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51001980 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48870303 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47474474 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43802685 |
| 42 | * MYB_26560356_Chip-Seq_TH1_Human | 1.42578364 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41158973 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40604666 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40526368 |
| 46 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40364404 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.39806234 |
| 48 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38655334 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37142173 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36518884 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35234659 |
| 52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34930234 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34684278 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34558938 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34495881 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33329987 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.33272620 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30715095 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30262194 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30247996 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29346740 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28932980 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28932980 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28516438 |
| 65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27297009 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25793803 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24992718 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23912144 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23024522 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21681714 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21067944 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20982196 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20725457 |
| 74 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.20292501 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20095770 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20090472 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19672376 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18493533 |
| 79 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18049186 |
| 80 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17425546 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17049636 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16534860 |
| 83 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15838421 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15377926 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14329965 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14172525 |
| 87 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13694058 |
| 88 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13461863 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13250721 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12549719 |
| 91 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12219471 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11775444 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11451713 |
| 94 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10192346 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08829612 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07401776 |
| 97 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07145940 |
| 98 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07131211 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06438072 |
| 100 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06436090 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05515101 |
| 102 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.03990776 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03592703 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03356533 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03257692 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02999039 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02902579 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02244746 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01423174 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01381473 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00777958 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00586369 |
| 113 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99546188 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99520033 |
| 115 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99474513 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99282887 |
| 117 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98985217 |
| 118 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98941179 |
| 119 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98139330 |
| 120 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95999049 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95787567 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94889076 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94855041 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94583084 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94558414 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94423179 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94257939 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93673283 |
| 129 | MYC_22102868_ChIP-Seq_BL_Human | 0.93009846 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92093329 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91662021 |
| 132 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91352521 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91081661 |
| 134 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90493405 |
| 135 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90296524 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90157028 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90025971 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89774322 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89120522 |
| 140 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88402154 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88334541 |
| 142 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87646315 |
| 143 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86567797 |
| 144 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86475360 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86216571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002132_abnormal_respiratory_system | 5.76505382 |
| 2 | MP0005360_urolithiasis | 4.37499148 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.37037500 |
| 4 | MP0005365_abnormal_bile_salt | 3.82218145 |
| 5 | MP0009840_abnormal_foam_cell | 3.61023005 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.38852234 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.03147385 |
| 8 | MP0000858_altered_metastatic_potential | 2.96071797 |
| 9 | MP0005671_abnormal_response_to | 2.84996847 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.72817403 |
| 11 | MP0003252_abnormal_bile_duct | 2.52869981 |
| 12 | MP0005083_abnormal_biliary_tract | 2.50924221 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.46220578 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.42951785 |
| 15 | MP0001873_stomach_inflammation | 2.40481792 |
| 16 | MP0002405_respiratory_system_inflammati | 2.32679772 |
| 17 | MP0005670_abnormal_white_adipose | 2.30512051 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.26070766 |
| 19 | MP0005451_abnormal_body_composition | 2.13979798 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.98232859 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.94680271 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.93513503 |
| 23 | MP0001819_abnormal_immune_cell | 1.92655760 |
| 24 | MP0005332_abnormal_amino_acid | 1.92107728 |
| 25 | MP0003195_calcinosis | 1.89542496 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.78488289 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.77251653 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.76427957 |
| 29 | MP0005408_hypopigmentation | 1.74694337 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.72236238 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.72162964 |
| 32 | MP0004883_abnormal_blood_vessel | 1.65029106 |
| 33 | MP0000609_abnormal_liver_physiology | 1.60734366 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.59026566 |
| 35 | MP0009278_abnormal_bone_marrow | 1.55223566 |
| 36 | MP0004510_myositis | 1.47212960 |
| 37 | MP0002398_abnormal_bone_marrow | 1.47121640 |
| 38 | MP0000716_abnormal_immune_system | 1.46820363 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.45958849 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.43923314 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.41392357 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.38895080 |
| 43 | MP0000685_abnormal_immune_system | 1.34044345 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.33836606 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.32613647 |
| 46 | MP0001790_abnormal_immune_system | 1.29021603 |
| 47 | MP0005387_immune_system_phenotype | 1.29021603 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.28900376 |
| 49 | MP0001663_abnormal_digestive_system | 1.26149514 |
| 50 | MP0002796_impaired_skin_barrier | 1.25764037 |
| 51 | MP0002722_abnormal_immune_system | 1.23639277 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22559674 |
| 53 | MP0003724_increased_susceptibility_to | 1.21999134 |
| 54 | MP0003436_decreased_susceptibility_to | 1.19197966 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.17457764 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.16857026 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.16233196 |
| 58 | MP0001756_abnormal_urination | 1.14147139 |
| 59 | MP0002429_abnormal_blood_cell | 1.13952033 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.13428021 |
| 61 | MP0003303_peritoneal_inflammation | 1.12790048 |
| 62 | MP0004130_abnormal_muscle_cell | 1.12425778 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.11002763 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.10445715 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.10366660 |
| 66 | MP0004947_skin_inflammation | 1.09886937 |
| 67 | MP0000604_amyloidosis | 1.08908595 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.08277523 |
| 69 | MP0008260_abnormal_autophagy | 1.08276418 |
| 70 | MP0008469_abnormal_protein_level | 1.07027993 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.05774836 |
| 72 | MP0005164_abnormal_response_to | 1.05007364 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.03846271 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.03846271 |
| 75 | MP0002933_joint_inflammation | 1.03792910 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 1.03475646 |
| 77 | MP0003868_abnormal_feces_composition | 1.03460771 |
| 78 | MP0004381_abnormal_hair_follicle | 1.03429494 |
| 79 | MP0002254_reproductive_system_inflammat | 1.02715568 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.01637797 |
| 81 | MP0002136_abnormal_kidney_physiology | 1.01478828 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.01233830 |
| 83 | MP0000490_abnormal_crypts_of | 1.00848748 |
| 84 | MP0004043_abnormal_pH_regulation | 1.00838172 |
| 85 | MP0002971_abnormal_brown_adipose | 0.99571259 |
| 86 | MP0001851_eye_inflammation | 0.97553577 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.97311233 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.96370811 |
| 89 | MP0005025_abnormal_response_to | 0.95135272 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.94783732 |
| 91 | MP0003045_fibrosis | 0.94377015 |
| 92 | MP0005166_decreased_susceptibility_to | 0.93998355 |
| 93 | MP0009764_decreased_sensitivity_to | 0.92941309 |
| 94 | MP0010155_abnormal_intestine_physiology | 0.92583440 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.92530692 |
| 96 | MP0002060_abnormal_skin_morphology | 0.90888290 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.90819846 |
| 98 | MP0001915_intracranial_hemorrhage | 0.89477811 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.89145425 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.87653008 |
| 101 | MP0005165_increased_susceptibility_to | 0.87593954 |
| 102 | MP0002419_abnormal_innate_immunity | 0.87124434 |
| 103 | MP0005334_abnormal_fat_pad | 0.86054617 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.85888160 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.85700313 |
| 106 | MP0008004_abnormal_stomach_pH | 0.85228229 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.84785081 |
| 108 | MP0005220_abnormal_exocrine_pancreas | 0.84443952 |
| 109 | MP0008438_abnormal_cutaneous_collagen | 0.83731455 |
| 110 | MP0000598_abnormal_liver_morphology | 0.83707873 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.83236213 |
| 112 | MP0003011_delayed_dark_adaptation | 0.83089616 |
| 113 | MP0000749_muscle_degeneration | 0.82777932 |
| 114 | MP0006082_CNS_inflammation | 0.82580090 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.81805059 |
| 116 | MP0001849_ear_inflammation | 0.81172111 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.80756212 |
| 118 | MP0001800_abnormal_humoral_immune | 0.80736478 |
| 119 | MP0001853_heart_inflammation | 0.80040545 |
| 120 | MP0004036_abnormal_muscle_relaxation | 0.79414676 |
| 121 | MP0000343_altered_response_to | 0.79189697 |
| 122 | MP0005330_cardiomyopathy | 0.79153849 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.77701021 |
| 124 | MP0009785_altered_susceptibility_to | 0.77383401 |
| 125 | MP0003828_pulmonary_edema | 0.76315045 |
| 126 | MP0008874_decreased_physiological_sensi | 0.76248880 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.75646657 |
| 128 | MP0000751_myopathy | 0.75038807 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.74852290 |
| 130 | MP0005310_abnormal_salivary_gland | 0.74730180 |
| 131 | MP0005000_abnormal_immune_tolerance | 0.74646331 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.74067588 |
| 133 | MP0003075_altered_response_to | 0.73329289 |
| 134 | MP0001216_abnormal_epidermal_layer | 0.72640234 |
| 135 | MP0002723_abnormal_immune_serum | 0.71387464 |
| 136 | MP0009763_increased_sensitivity_to | 0.70849923 |
| 137 | MP0000249_abnormal_blood_vessel | 0.70178624 |
| 138 | MP0003329_amyloid_beta_deposits | 0.69105908 |
| 139 | MP0005275_abnormal_skin_tensile | 0.68729197 |
| 140 | MP0000383_abnormal_hair_follicle | 0.68372662 |
| 141 | MP0003690_abnormal_glial_cell | 0.67779016 |
| 142 | MP0003866_abnormal_defecation | 0.67678210 |
| 143 | MP0003183_abnormal_peptide_metabolism | 0.66470302 |
| 144 | MP0004084_abnormal_cardiac_muscle | 0.66394387 |
| 145 | MP0003279_aneurysm | 0.63848910 |
| 146 | MP0003448_altered_tumor_morphology | 0.63487761 |
| 147 | MP0005390_skeleton_phenotype | 0.61417633 |
| 148 | MP0000920_abnormal_myelination | 0.59880947 |
| 149 | MP0004858_abnormal_nervous_system | 0.58780485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 7.12919117 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.52763027 |
| 3 | Myositis (HP:0100614) | 5.28079544 |
| 4 | Zonular cataract (HP:0010920) | 4.98386602 |
| 5 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.69645407 |
| 6 | Xanthomatosis (HP:0000991) | 4.54000168 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.51869875 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.25445875 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.91901971 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.87084338 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.74467986 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.66445744 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.64400116 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.63536128 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.62132771 |
| 16 | Thrombocytosis (HP:0001894) | 3.58273603 |
| 17 | Complement deficiency (HP:0004431) | 3.48904033 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 3.46668788 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.43759600 |
| 20 | Ketosis (HP:0001946) | 3.29806777 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.21364846 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.20429571 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.11423369 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.10014451 |
| 25 | Orchitis (HP:0100796) | 3.07907047 |
| 26 | Stridor (HP:0010307) | 3.05973388 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.05269952 |
| 28 | Diaphragmatic weakness (HP:0009113) | 3.03137044 |
| 29 | Ketoacidosis (HP:0001993) | 3.02761111 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.00932949 |
| 31 | Late onset (HP:0003584) | 2.98722013 |
| 32 | Generalized aminoaciduria (HP:0002909) | 2.97793376 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.97405064 |
| 34 | Meningitis (HP:0001287) | 2.91204939 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 2.90443736 |
| 36 | Hyperglycinuria (HP:0003108) | 2.88798493 |
| 37 | Abnormality of T cells (HP:0002843) | 2.86267228 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.82635241 |
| 39 | Abnormality of complement system (HP:0005339) | 2.81415617 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.81283996 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81283996 |
| 42 | Hyperammonemia (HP:0001987) | 2.77377188 |
| 43 | Gout (HP:0001997) | 2.75847641 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74517536 |
| 45 | Obstructive lung disease (HP:0006536) | 2.74517536 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.73380743 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.73368460 |
| 48 | Increased IgE level (HP:0003212) | 2.73162965 |
| 49 | Pustule (HP:0200039) | 2.72592284 |
| 50 | Optic neuritis (HP:0100653) | 2.69911722 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.69911722 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.68072550 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67126414 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.67126414 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.66973256 |
| 56 | Increased serum ferritin (HP:0003281) | 2.66091892 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65654678 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.61423891 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61072616 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.60628774 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60507735 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60507735 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60507735 |
| 64 | Axonal loss (HP:0003447) | 2.59898124 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59712928 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.59333429 |
| 67 | Gingivitis (HP:0000230) | 2.57755035 |
| 68 | Cellulitis (HP:0100658) | 2.57246334 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.57214505 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.55856050 |
| 71 | Urticaria (HP:0001025) | 2.55746213 |
| 72 | Recurrent skin infections (HP:0001581) | 2.54764218 |
| 73 | Joint hemorrhage (HP:0005261) | 2.53249209 |
| 74 | Stomatitis (HP:0010280) | 2.52089846 |
| 75 | Cheilitis (HP:0100825) | 2.50295832 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49511571 |
| 77 | Mediastinal lymphadenopathy (HP:0100721) | 2.49230519 |
| 78 | Glomerulonephritis (HP:0000099) | 2.47317134 |
| 79 | Encephalitis (HP:0002383) | 2.45873108 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45389808 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.45389808 |
| 82 | Epidermoid cyst (HP:0200040) | 2.45184959 |
| 83 | Hyperglycinemia (HP:0002154) | 2.40851200 |
| 84 | Purpura (HP:0000979) | 2.40832548 |
| 85 | Myocardial infarction (HP:0001658) | 2.40779006 |
| 86 | Vascular calcification (HP:0004934) | 2.40438241 |
| 87 | Megaloblastic anemia (HP:0001889) | 2.38879504 |
| 88 | Chest pain (HP:0100749) | 2.38154453 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.38102219 |
| 90 | Poikilocytosis (HP:0004447) | 2.37690031 |
| 91 | Cerebral inclusion bodies (HP:0100314) | 2.35086561 |
| 92 | Vasculitis (HP:0002633) | 2.34148227 |
| 93 | Myoglobinuria (HP:0002913) | 2.31800838 |
| 94 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31321540 |
| 95 | Fat malabsorption (HP:0002630) | 2.30266829 |
| 96 | Petechiae (HP:0000967) | 2.27531728 |
| 97 | Hypochromic anemia (HP:0001931) | 2.27230233 |
| 98 | Polycythemia (HP:0001901) | 2.24473920 |
| 99 | Epistaxis (HP:0000421) | 2.21155420 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 2.21092098 |
| 101 | Ventricular tachycardia (HP:0004756) | 2.18680190 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.18099466 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.17965211 |
| 104 | Cardiovascular calcification (HP:0011915) | 2.17803458 |
| 105 | Gastrointestinal inflammation (HP:0004386) | 2.17045181 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17041180 |
| 107 | Esophageal varix (HP:0002040) | 2.16290106 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15923896 |
| 109 | Inflammation of the large intestine (HP:0002037) | 2.14592117 |
| 110 | Hypolipoproteinemia (HP:0010981) | 2.14404904 |
| 111 | Hemoptysis (HP:0002105) | 2.12977842 |
| 112 | Amyloidosis (HP:0011034) | 2.12752616 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10477738 |
| 114 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10477738 |
| 115 | Hypertriglyceridemia (HP:0002155) | 2.10124113 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 2.08296595 |
| 117 | Arterial thrombosis (HP:0004420) | 2.05962461 |
| 118 | Mitral stenosis (HP:0001718) | 2.03578210 |
| 119 | Spinal muscular atrophy (HP:0007269) | 2.03361860 |
| 120 | Increased IgM level (HP:0003496) | 2.03351065 |
| 121 | Emphysema (HP:0002097) | 2.02343558 |
| 122 | Impaired platelet aggregation (HP:0003540) | 2.01336348 |
| 123 | Abnormal platelet function (HP:0011869) | 2.01336348 |
| 124 | Hypoglycemic seizures (HP:0002173) | 1.98858023 |
| 125 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98042602 |
| 126 | Hemiplegia (HP:0002301) | 1.97924250 |
| 127 | Keratoconjunctivitis sicca (HP:0001097) | 1.97411675 |
| 128 | Nephritis (HP:0000123) | 1.97310306 |
| 129 | Pancreatitis (HP:0001733) | 1.97171127 |
| 130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96967666 |
| 131 | Malnutrition (HP:0004395) | 1.96473133 |
| 132 | Joint stiffness (HP:0001387) | 1.94040367 |
| 133 | Hyporeflexia of lower limbs (HP:0002600) | 1.93793308 |
| 134 | Skin nodule (HP:0200036) | 1.92605250 |
| 135 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92593725 |
| 136 | Hyperbilirubinemia (HP:0002904) | 1.92312650 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.91923777 |
| 138 | Erythema (HP:0010783) | 1.91787095 |
| 139 | Metabolic acidosis (HP:0001942) | 1.88774043 |
| 140 | Protuberant abdomen (HP:0001538) | 1.88575367 |
| 141 | Osteomyelitis (HP:0002754) | 1.88499947 |
| 142 | Eczematoid dermatitis (HP:0000976) | 1.87290387 |
| 143 | Agammaglobulinemia (HP:0004432) | 1.87138682 |
| 144 | Premature loss of primary teeth (HP:0006323) | 1.87020122 |
| 145 | Cerebral aneurysm (HP:0004944) | 1.86736242 |
| 146 | Abnormality of T cell number (HP:0011839) | 1.86517463 |
| 147 | Alkalosis (HP:0001948) | 1.86278064 |
| 148 | Hemorrhage of the eye (HP:0011885) | 1.85585796 |
| 149 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85213588 |
| 150 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84799302 |
| 151 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84799302 |
| 152 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84799302 |
| 153 | Proximal tubulopathy (HP:0000114) | 1.84712586 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.83683532 |
| 155 | Glycosuria (HP:0003076) | 1.83683532 |
| 156 | Recurrent viral infections (HP:0004429) | 1.82084863 |
| 157 | Spontaneous hematomas (HP:0007420) | 1.81785483 |
| 158 | Increased purine levels (HP:0004368) | 1.80578664 |
| 159 | Hyperuricemia (HP:0002149) | 1.80578664 |
| 160 | Hypochromic microcytic anemia (HP:0004840) | 1.80063790 |
| 161 | Fatigue (HP:0012378) | 1.79865528 |
| 162 | Gingival bleeding (HP:0000225) | 1.79814474 |
| 163 | Gastrointestinal stroma tumor (HP:0100723) | 1.76878858 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76458264 |
| 165 | Abdominal distention (HP:0003270) | 1.76064512 |
| 166 | Sudden death (HP:0001699) | 1.75514763 |
| 167 | Keratoconjunctivitis (HP:0001096) | 1.74785124 |
| 168 | Alopecia of scalp (HP:0002293) | 1.74732142 |
| 169 | T lymphocytopenia (HP:0005403) | 1.73979503 |
| 170 | Ileus (HP:0002595) | 1.73914521 |
| 171 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.73769287 |
| 172 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73769287 |
| 173 | Pulmonary embolism (HP:0002204) | 1.72246978 |
| 174 | Hematuria (HP:0000790) | 1.71049954 |
| 175 | Autoimmune thrombocytopenia (HP:0001973) | 1.70728579 |
| 176 | Leukocytosis (HP:0001974) | 1.70149478 |
| 177 | Steatorrhea (HP:0002570) | 1.69227607 |
| 178 | Hypokalemic alkalosis (HP:0001949) | 1.68590668 |
| 179 | Hepatocellular carcinoma (HP:0001402) | 1.68166321 |
| 180 | Colitis (HP:0002583) | 1.67097681 |
| 181 | Abnormality of the nasal mucosa (HP:0000433) | 1.66498720 |
| 182 | Vomiting (HP:0002013) | 1.65820084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.83165625 |
| 2 | BCKDK | 3.00107386 |
| 3 | RIPK4 | 2.91165249 |
| 4 | EPHB1 | 2.89795310 |
| 5 | TRIB3 | 2.87381973 |
| 6 | TGFBR2 | 2.61925265 |
| 7 | PRPF4B | 2.55409346 |
| 8 | MAP4K1 | 2.32903977 |
| 9 | FGFR4 | 2.31218410 |
| 10 | SIK1 | 2.30449339 |
| 11 | TAOK3 | 2.28653383 |
| 12 | FES | 2.08899355 |
| 13 | MET | 1.96223149 |
| 14 | PRKG2 | 1.94143278 |
| 15 | TYK2 | 1.88031299 |
| 16 | WNK4 | 1.85242781 |
| 17 | PKN2 | 1.84101348 |
| 18 | MAPK7 | 1.79701671 |
| 19 | INSRR | 1.77254719 |
| 20 | TNK2 | 1.75386610 |
| 21 | TTN | 1.74338834 |
| 22 | MAP3K10 | 1.74177501 |
| 23 | TBK1 | 1.73056669 |
| 24 | BMX | 1.70364713 |
| 25 | MAP2K2 | 1.66418123 |
| 26 | PTK6 | 1.64372460 |
| 27 | TAOK1 | 1.52271616 |
| 28 | PAK4 | 1.37114425 |
| 29 | CSF1R | 1.35838940 |
| 30 | IRAK3 | 1.33121059 |
| 31 | TIE1 | 1.32026542 |
| 32 | LRRK2 | 1.27045927 |
| 33 | MST1R | 1.24960338 |
| 34 | ZAP70 | 1.24084074 |
| 35 | STK10 | 1.23813812 |
| 36 | MAPK15 | 1.22583498 |
| 37 | STK39 | 1.21702654 |
| 38 | MAP3K3 | 1.21678590 |
| 39 | MAP3K7 | 1.20365429 |
| 40 | TESK2 | 1.19768139 |
| 41 | CAMK1D | 1.19606438 |
| 42 | MAP2K3 | 1.17571995 |
| 43 | JAK1 | 1.14756012 |
| 44 | JAK2 | 1.12183497 |
| 45 | EPHA3 | 1.12015339 |
| 46 | CSK | 1.09837446 |
| 47 | SMG1 | 1.07347188 |
| 48 | IKBKE | 1.03773040 |
| 49 | JAK3 | 1.03772047 |
| 50 | CDK4 | 1.02790972 |
| 51 | MAP3K13 | 1.02004310 |
| 52 | BLK | 1.01870243 |
| 53 | TAOK2 | 1.01852039 |
| 54 | MAP3K14 | 1.00027609 |
| 55 | BTK | 0.99740626 |
| 56 | TXK | 0.98956334 |
| 57 | GRK6 | 0.98784889 |
| 58 | KDR | 0.98594787 |
| 59 | CAMK1G | 0.97618571 |
| 60 | EEF2K | 0.96927505 |
| 61 | CDC42BPA | 0.95938275 |
| 62 | LYN | 0.95804694 |
| 63 | DMPK | 0.95091255 |
| 64 | PTK2 | 0.94684030 |
| 65 | PIK3CG | 0.93061205 |
| 66 | SIK3 | 0.92737738 |
| 67 | MAP3K2 | 0.90578237 |
| 68 | PIM1 | 0.90375891 |
| 69 | MAPK11 | 0.87797765 |
| 70 | PRKD1 | 0.87320496 |
| 71 | HIPK2 | 0.85640189 |
| 72 | RIPK1 | 0.81269086 |
| 73 | ITK | 0.80433378 |
| 74 | MAP3K1 | 0.77320587 |
| 75 | DYRK1B | 0.76250259 |
| 76 | MAP3K12 | 0.75879681 |
| 77 | NLK | 0.75674863 |
| 78 | CLK1 | 0.74175353 |
| 79 | FGR | 0.74130159 |
| 80 | PRKD2 | 0.73963545 |
| 81 | MYLK | 0.71986651 |
| 82 | PDPK1 | 0.71885273 |
| 83 | PRKAA2 | 0.70509046 |
| 84 | LMTK2 | 0.68898684 |
| 85 | FLT3 | 0.67210127 |
| 86 | MAP3K11 | 0.65216672 |
| 87 | GSK3A | 0.65097714 |
| 88 | MAPK12 | 0.64712326 |
| 89 | PTK2B | 0.64643991 |
| 90 | IKBKB | 0.64110352 |
| 91 | PDGFRB | 0.63469790 |
| 92 | TESK1 | 0.62394969 |
| 93 | STK38 | 0.62363163 |
| 94 | IRAK2 | 0.61131957 |
| 95 | PKN1 | 0.59268986 |
| 96 | OBSCN | 0.58977164 |
| 97 | SIK2 | 0.58853865 |
| 98 | OXSR1 | 0.58767990 |
| 99 | FYN | 0.57652482 |
| 100 | MATK | 0.57109308 |
| 101 | PDK1 | 0.56990522 |
| 102 | GRK7 | 0.56670453 |
| 103 | RET | 0.56555270 |
| 104 | NME2 | 0.55330441 |
| 105 | MARK3 | 0.52734802 |
| 106 | NEK9 | 0.52478418 |
| 107 | KSR2 | 0.52309731 |
| 108 | PHKG1 | 0.51775803 |
| 109 | PHKG2 | 0.51775803 |
| 110 | ILK | 0.51411697 |
| 111 | PRKCZ | 0.50671212 |
| 112 | HCK | 0.49825181 |
| 113 | MAPK4 | 0.49067640 |
| 114 | LCK | 0.49066192 |
| 115 | PRKCH | 0.48133553 |
| 116 | PRKCQ | 0.47157753 |
| 117 | KIT | 0.46700766 |
| 118 | FGFR3 | 0.46513567 |
| 119 | RPS6KC1 | 0.46094973 |
| 120 | RPS6KL1 | 0.46094973 |
| 121 | EPHB2 | 0.43960669 |
| 122 | IRAK4 | 0.43776579 |
| 123 | LATS1 | 0.43231687 |
| 124 | ICK | 0.43076400 |
| 125 | MARK2 | 0.42015549 |
| 126 | RPS6KA6 | 0.41786253 |
| 127 | SYK | 0.39968335 |
| 128 | EGFR | 0.39024243 |
| 129 | RPS6KA2 | 0.38994495 |
| 130 | TEC | 0.38483999 |
| 131 | MTOR | 0.37783503 |
| 132 | MAP3K6 | 0.37385136 |
| 133 | CHUK | 0.37135127 |
| 134 | WNK1 | 0.37054857 |
| 135 | EPHA2 | 0.33697711 |
| 136 | MAP2K6 | 0.31245585 |
| 137 | CAMKK1 | 0.29921001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.23605577 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.85959782 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.70076161 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.63551340 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53601244 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42581339 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39467192 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.38474710 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36176349 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.25635888 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25051073 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23375848 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22020228 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21976354 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.15090522 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.06006802 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05529913 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 2.03680426 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01990247 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96067441 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.94099112 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88289135 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86323010 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84737070 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83623515 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82742229 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79093420 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76641289 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76205800 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69738872 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69417024 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.69290152 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64756153 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64297374 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62959511 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62668186 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57379586 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56072143 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55941609 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55087511 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53475861 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53227068 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51075845 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46777951 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.44265874 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44026444 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39237274 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36515011 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.35948321 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31911343 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31565086 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.28590802 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22300569 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20436267 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.19344927 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18639408 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17750844 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16377427 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15940042 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 1.14708966 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12552638 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10330438 |
| 63 | Asthma_Homo sapiens_hsa05310 | 1.08748100 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 1.08706392 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08347960 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06183181 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 1.06000506 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05791597 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04554333 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04193082 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 1.01981400 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99843518 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99761293 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99738759 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99175909 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98148710 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96167063 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95674922 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94152432 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94083898 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93909103 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91678046 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89895684 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88081371 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.88033958 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.87874858 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86213999 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85050347 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.84354840 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84313431 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.80135863 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79813513 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79670447 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79617216 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78446579 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.78314699 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77327589 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77162121 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76101657 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75764682 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72650878 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.72623562 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72602050 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72564498 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72022302 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69592467 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69337935 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68918312 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67080877 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66543257 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66319658 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65746741 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64205893 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61477546 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.60575231 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58570300 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.58322986 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57765886 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57197491 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56938444 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.56162371 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56092280 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55265266 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55060479 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54678419 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54354171 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53708048 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53105189 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52903571 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52546631 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51695604 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49016242 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48880830 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48496999 |
| 135 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48359455 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47546160 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47539426 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46985561 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46835865 |
| 140 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46696421 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46167843 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46012032 |
| 143 | Bladder cancer_Homo sapiens_hsa05219 | 0.44677722 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44425441 |
| 145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43744497 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43098146 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41742995 |
| 148 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40038390 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37829052 |
| 150 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37200575 |
| 151 | Pertussis_Homo sapiens_hsa05133 | 0.36823544 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35998969 |
| 153 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35660640 |
| 154 | Amoebiasis_Homo sapiens_hsa05146 | 0.35399194 |
| 155 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34475525 |
| 156 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32486979 |
| 157 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31976455 |
| 158 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.31770839 |
| 159 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31492286 |
| 160 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30907519 |
| 161 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30669936 |
| 162 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30255990 |
| 163 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29434314 |
| 164 | Focal adhesion_Homo sapiens_hsa04510 | 0.27802088 |
| 165 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26597643 |
| 166 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26075792 |
| 167 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25028437 |
| 168 | Prion diseases_Homo sapiens_hsa05020 | 0.22975181 |
| 169 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22334420 |

